Novel synthetic suppressor tRNA have been provided which provide read-throughof internal nonsense mutations, or which can site-specifically altertranslation of transcribed sequences. Uses of the same are also provided ingenetic engineering protocols including gene therapy treatment of diseasessuch as Xeroderma pigmentosum.